How can I manage uncontrolled systolic hypertension (~180 mmHg) in a post‑coronary artery bypass grafting (CABG) patient taking lisinopril 20 mg daily and metoprolol 100 mg twice daily who wants fewer pills?

Add a Calcium Channel Blocker to Your Current Regimen

Switch to a single-pill combination of lisinopril/amlodipine (ACE inhibitor + calcium channel blocker) to reduce pill burden while adding the necessary third drug class for better blood pressure control. This approach directly addresses your patient's preference for fewer pills while following evidence-based guidelines for uncontrolled hypertension in post-CABG patients.

Why This Strategy Works

Your patient is currently on only two antihypertensive drug classes (ACE inhibitor and beta-blocker), with a systolic BP in the 180s—far above the target of 120-129 mmHg 1. The 2024 ESC and 2025 AHA/ACC guidelines are clear: most patients with confirmed hypertension require combination therapy from multiple drug classes, preferably as single-pill combinations 1.

The Optimal Drug Combination

The guidelines specifically recommend a three-drug regimen consisting of:

• RAS blocker (ACE inhibitor or ARB)
• Calcium channel blocker (CCB)
• Thiazide/thiazide-like diuretic

1

Your patient already has the ACE inhibitor (lisinopril 20 mg). The next step is adding a dihydropyridine calcium channel blocker like amlodipine, which can be combined with lisinopril in a single pill 1. This addresses the pill burden concern immediately.

Why Not Just Increase Current Medications?

While lisinopril can be increased to 40 mg daily 2, and metoprolol is already at a reasonable dose (100 mg BID), beta-blockers are not considered first-line for blood pressure reduction in hypertension—they're indicated post-CABG for their cardioprotective effects (angina, post-MI protection, heart rate control) 1, 3. The guidelines explicitly state that ACE inhibitors, ARBs, CCBs, and diuretics are the four major first-line classes for BP lowering 1.

Specific Recommendation

1. Switch from separate lisinopril 20 mg to a fixed-dose combination pill containing lisinopril/amlodipine (start with 20/5 mg or 20/10 mg depending on tolerance concerns)

2. Continue metoprolol 100 mg BID (essential for post-CABG cardioprotection) 1, 3

3. If BP remains uncontrolled after 1-3 months, add a thiazide-like diuretic (chlorthalidone or indapamide preferred over hydrochlorothiazide) as a third agent, ideally finding a triple-combination single pill if available 1

Evidence in Post-CABG Patients

A study specifically in post-CABG patients demonstrated that fixed lisinopril/amlodipine combination was safe, highly effective, and achieved target BP in practically all patients 4. This validates the approach in your exact patient population.

If Triple Therapy Is Still Insufficient

Should BP remain elevated (which would classify this as resistant hypertension), the 2025 AHA/ACC guidelines recommend:

• Add spironolactone (mineralocorticoid receptor antagonist) as the fourth agent if eGFR ≥45 mL/min/1.73 m² 5
• Check medication adherence and screen for secondary causes 5
• Consider alternatives like eplerenone, amiloride, or vasodilating beta-blockers if spironolactone is contraindicated 5, 1

Critical Pitfalls to Avoid

• Don't combine two RAS blockers (ACE inhibitor + ARB)—this is explicitly not recommended 1
• Don't rely solely on increasing beta-blocker doses for BP control—their antihypertensive effect is less potent than other first-line agents 1
• Don't forget to assess for interfering medications (NSAIDs, decongestants) that may elevate BP 5
• Monitor renal function and potassium when using ACE inhibitors, especially if adding spironolactone later 5

Target Blood Pressure

Aim for systolic BP of 120-129 mmHg in this post-CABG patient, as recommended by the most recent 2024 ESC guidelines 1. This target reduces cardiovascular risk when treatment is well tolerated.